ENABLE-2

Supporting the early stages of discovery and development of new antibiotics

Welcome to ENABLE-2

ENABLE-2 is an antibacterial drug discovery platform with focus on the early stages of antibiotic discovery and development. ENABLE-2 supports the development of direct acting systemic antibacterial compounds to ensure a sustainable flow of new antibacterial drug candidates into the development pipeline.

ENABLE-2 is based on learnings from ENABLE (Innovative Medicines Initiative) and supported by the Swedish Research Council and the National Research Programme on Antibiotic Resistance.

ENABLE-2 Logos
Last modified: 2024-04-10